The Ferring Innovation Grants program is sponsored by Ferring Research Institute (FRI) and funds research designed to identify and validate new molecular targets in Ferring ’s core therapeutic areas.

Located in San Diego, California, FRI is the global peptide therapeutics research centre for Ferring Pharmaceuticals.

FRI is interested in funding exploratory, discovery and preclinical research into novel extracellular drug targets that are addressable with peptides and/or proteins in the following therapeutic areas:
  • Reproductive Health
  • Urology
  • Gastroenterology
  • Endocrinology

For more detailed information and to submit an application, please visit the Ferring Innovation Grants page at: Ferring-research.com

Ferring B.V. gebruikt Google Analytics om uw gebruik van onze websites te analyseren,
zodat we functionaliteiten daarop kunnen aanpassen.
Meer informatie is beschikbaar in ons Privacybeleid.
Indien u hier niet mee akkoord gaat kunt u de website nu sluiten.

People come first

'We embrace a different philosophy at Ferring. With Ferring, it is people who come first, not quarterly price earnings. It is the confidence and trust of our patients and prescribing physicians, the ethical approach and loyalty of our employees and the respect that the company shows to all 'our people'- our stakeholders - that build the foundation of Ferring's success'.
Frederik Paulsen

'Samenwerken'

'Wij zijn op zoek naar partijen en vernieuwende ideeën om de patiëntenzorg, inclusief het gebruik van medicatie, te verbeteren. Als alle belanghebbenden binnen een zorgtraject hierin samenwerken, is de kans op duurzaam succes het grootst.’

Guido Koster, Director External Affairs